76 related articles for article (PubMed ID: 9772705)
1. [Preparation of hepatic targeting antivirus agent NGA-ACV and its targeting property].
Fan JZ; Li TL; Pang QJ; Guan CT; He Y; Su KY
Yao Xue Xue Bao; 1996; 31(8):585-90. PubMed ID: 9772705
[TBL] [Abstract][Full Text] [Related]
2. [Galactosyl neoglycoalbumin:preparation and studies of its binding with hepatic special receptor].
Pang Q; Yang L; Zhong Y; Guan C; Zhao Q; Tan T
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):368-71. PubMed ID: 1814813
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of (99m)Tc-DMP-NGA as a novel hepatic asialoglycoprotein receptor imaging agent.
Yang W; Mou T; Zhang X; Wang X
Appl Radiat Isot; 2010 Jan; 68(1):105-9. PubMed ID: 19815422
[TBL] [Abstract][Full Text] [Related]
4. [The preparation of hepatic receptor imaging agent 99mTc-DTPA-NGA].
Li Y; Guan C; Wang Q
Hua Xi Yi Ke Da Xue Xue Bao; 1996 Mar; 27(1):54-8. PubMed ID: 9208621
[TBL] [Abstract][Full Text] [Related]
5. Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits.
Chetoni P; Rossi S; Burgalassi S; Monti D; Mariotti S; Saettone MF
J Ocul Pharmacol Ther; 2004 Apr; 20(2):169-77. PubMed ID: 15117573
[TBL] [Abstract][Full Text] [Related]
6. Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistry.
Vera DR
J Nucl Med; 1992 Jun; 33(6):1160-6. PubMed ID: 1597732
[TBL] [Abstract][Full Text] [Related]
7. Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes.
Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
Radiology; 1984 Apr; 151(1):191-6. PubMed ID: 6701314
[TBL] [Abstract][Full Text] [Related]
8. Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization.
Arano Y; Wakisaka K; Ohmomo Y; Uezono T; Mukai T; Motonari H; Shiono H; Sakahara H; Konishi J; Tanaka C
J Med Chem; 1994 Aug; 37(16):2609-18. PubMed ID: 8057303
[TBL] [Abstract][Full Text] [Related]
9. In vivo application of chitosan to facilitate intestinal acyclovir absorption in rats.
Masuda A; Goto Y; Kurosaki Y; Aiba T
J Pharm Sci; 2012 Jul; 101(7):2449-56. PubMed ID: 22535511
[TBL] [Abstract][Full Text] [Related]
10. [Study of pharmacokinetics of liver targeting antimalarial agent neoglycoalbumin-primaquine conjugate (NGA-PQ) and primaquine phosphate in mouse].
Li TL; Pang QJ; He YL; Wang P
Yao Xue Xue Bao; 1995; 30(10):721-5. PubMed ID: 8701725
[TBL] [Abstract][Full Text] [Related]
11. Targeted lipid based drug conjugates: a novel strategy for drug delivery.
Vadlapudi AD; Vadlapatla RK; Kwatra D; Earla R; Samanta SK; Pal D; Mitra AK
Int J Pharm; 2012 Sep; 434(1-2):315-24. PubMed ID: 22692074
[TBL] [Abstract][Full Text] [Related]
12. Determination of acyclovir in renal microdialysis fluid and confirmation of renal function index.
Shen Z; Yu Q; Li Y; Bao Y; Lu H
Drug Chem Toxicol; 2020 Nov; 43(6):574-580. PubMed ID: 30486699
[TBL] [Abstract][Full Text] [Related]
13. Functional liver imaging with 99Tcm-galactosyl-neoglycoalbumin (NGA) in alcoholic liver cirrhosis and liver fibrosis.
Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
Nucl Med Commun; 1991 Jun; 12(6):507-17. PubMed ID: 1866104
[TBL] [Abstract][Full Text] [Related]
14. In vivo quantification of acyclovir exposure in the dermis following iontophoresis of semisolid formulations.
Shukla C; Friden P; Juluru R; Stagni G
J Pharm Sci; 2009 Mar; 98(3):917-25. PubMed ID: 18623192
[TBL] [Abstract][Full Text] [Related]
15. Vitreous disposition of two acycloguanosine antivirals in the albino and pigmented rabbit models: a novel ocular microdialysis technique.
Hughes PM; Krishnamoorthy R; Mitra AK
J Ocul Pharmacol Ther; 1996; 12(2):209-24. PubMed ID: 8773936
[TBL] [Abstract][Full Text] [Related]
16. Topical delivery of different acyclovir palmitate liposome formulations through rat skin in vitro.
Liu H; Pan WS; Tang R; Luo SD
Pharmazie; 2004 Mar; 59(3):203-6. PubMed ID: 15074594
[TBL] [Abstract][Full Text] [Related]
17. Assessment of correlation between skin target site free drug concentration and the in vivo topical antiviral efficacy in hairless mice for (E)-5-(2-bromovinyl)-2'-deoxyuridine and acyclovir formulations.
Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; De Clercq E; El-Shattawy HH
J Pharm Sci; 1998 Aug; 87(8):917-21. PubMed ID: 9687333
[TBL] [Abstract][Full Text] [Related]
18. Tc-NGA imaging in liver transplantation: preliminary clinical experience.
Woodle ES; Ward RE; Stadalnik RC; Vera DR
Surgery; 1989 Mar; 105(3):401-7. PubMed ID: 2646744
[TBL] [Abstract][Full Text] [Related]
19. Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits.
Stella B; Arpicco S; Rocco F; Burgalassi S; Nicosia N; Tampucci S; Chetoni P; Cattel L
Eur J Pharm Biopharm; 2012 Jan; 80(1):39-45. PubMed ID: 22008147
[TBL] [Abstract][Full Text] [Related]
20. [Effects of honey to acyclovir in the rabbit eye transport kinetics].
He Q; Wang S; Zhang X; Zhang J; Jiang Y; Xu J
Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2723-6. PubMed ID: 22242438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
